Los Angeles Capital Management
PTGX icon

Los Angeles Capital Management’s Protagonist Therapeutics PTGX Stock Holding History

Los Angeles Capital Management’s Portfolio PTGX Stock Details PTGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$498K Hold
4,727
– – ﹤0.01% 878
2025
Q4 		$368K Buy
+4,727
New +$387K ﹤0.01% 1016
2025
Q1 		– Sell
-31,366
Closed -$1.21M – 1192
2024
Q4 		$1.21M Buy
31,366
+8,920
+40% +$389K ﹤0.01% 562
2024
Q3 		$1.01M Sell
22,446
-8,381
-27% -$339K ﹤0.01% 652
2024
Q2 		$1.07M Hold
30,827
– – ﹤0.01% 636
2024
Q1 		$892K Buy
30,827
+21,673
+237% +$590K ﹤0.01% 726
2023
Q4 		$210K Buy
+9,154
New +$160K ﹤0.01% 1088
2023
Q3 		– Sell
-9,366
Closed -$259K – 1214
2023
Q2 		$259K Sell
9,366
-36,107
-79% -$904K ﹤0.01% 1053
2023
Q1 		$1.05M Sell
45,473
-31,517
-41% -$529K ﹤0.01% 652
2022
Q4 		$840K Hold
76,990
– – ﹤0.01% 750
2022
Q3 		$649K Buy
76,990
+6,060
+9% +$57.3K ﹤0.01% 843
2022
Q2 		$561K Buy
+70,930
New +$858K ﹤0.01% 925
2021
Q2 		– Sell
-47,387
Closed -$1.23M – 1652
2021
Q1 		$1.23M Sell
47,387
-620
-1% -$15.7K 0.01% 804
2020
Q4 		$968K Buy
48,007
+1,300
+3% +$28K ﹤0.01% 957
2020
Q3 		$913K Hold
46,707
– – ﹤0.01% 857
2020
Q2 		$825K Buy
46,707
+17,590
+60% +$221K ﹤0.01% 920
2020
Q1 		$206K Buy
+29,117
New +$218K ﹤0.01% 1168

Other funds holding PTGX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return

Los Angeles Capital Management's PTGX Position: Q1 2026 in Review

Los Angeles Capital Management held its Protagonist Therapeutics (PTGX) position steady in Q1 2026 at 4,727 shares worth $498K. The position accounts for ﹤0.01% of the portfolio, ranked #878.

Los Angeles Capital Management first reported a position in PTGX in Q1 2020 and has held it in 17 quarters since. The position peaked at $1.23M in Q1 2021. 318 funds tracked by Wall St. Rank hold PTGX as of Q1 2026.

  • Los Angeles Capital Management held 4,727 shares of Protagonist Therapeutics worth $498K as of Q1 2026.
  • Los Angeles Capital Management left its Protagonist Therapeutics share count unchanged in Q1 2026.
  • Protagonist Therapeutics made up ﹤0.01% of Los Angeles Capital Management's portfolio in Q1 2026, its #878 holding.
  • Los Angeles Capital Management first reported a position in Protagonist Therapeutics in Q1 2020 and has held it in 17 quarters since.
  • Los Angeles Capital Management's Protagonist Therapeutics position peaked at $1.23M in Q1 2021.
  • 318 funds tracked by Wall St. Rank held Protagonist Therapeutics as of Q1 2026.

Based on Los Angeles Capital Management's 13F filing for Q1 2026, filed 8 May 2026.